Harte-Hanks (HHS) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.55 +0.22%
Financial Fact:
Total nonoperating expenses (income): 814K
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Total nonoperating expenses (income): 814K
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Harte-Hanks (NYSE: HHS) reported Q2 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $97.3 million versus the consensus estimate of $116.25 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
- Forgent Power Solutions jumps as Bernstein sees massive earnings upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
